New HIV drug could revolutionize treatment for the elderly
A new once-daily HIV drug could simplify treatment for elderly patients who have been managing the virus for decades.
The first clinical trial to 'reprogram' human aging is launched
The first human clinical trial aimed at reversing aging processes has begun, announced by Dr. David Sinclair at the World Government Summit.
New GLP1 pill helps patients lose up to 8% of body weight, trial shows
A new daily pill called orforglipron shows promise in helping patients lose weight, according to a clinical trial, potentially offering a non-injection alternative to existing GLP-1 medications.
A single daily pill against HIV to replace more complex treatments in patients with resistances
New research suggests that a single daily pill combining two medications may effectively substitute more complex HIV treatments.
We will survive, but we are often exhausted. This is not often talked about in the office, says the coordinator of a survey on the lives of cancer patients
The article discusses the psychological and emotional challenges faced by cancer patients, particularly those undergoing the 'watch and wait' treatment approach, highlighting their struggle to balance everyday life and the lack of awareness regarding clinical trial opportunities.
Ayahuasca psychedelic DMT shows promise as depression therapy
A study indicates that DMT, a key component of the psychedelic ayahuasca, may effectively reduce depression symptoms in patients.
Novo on the way with a new weight loss drug
Novo Nordisk has released data from a study on a weight loss drug developed in collaboration with Chinese company United Biotechnology, showing significant weight loss among participants.
Novo Nordisk's shares plummet more than 16% after results of new drug
Novo Nordisk's shares sharply declined following disappointing clinical trial results of its new weight-loss drug, CagriSema, which underperformed compared to a competitor's product.
Novo Nordisk: 15% Drop in Stock - Why the Clinical Trial of CagriSema Was Disappointing
Novo Nordisk's stock plummeted 15% after its new drug CagriSema failed to meet key weight-loss targets in a clinical trial compared to Eli Lilly's tirzepatide.
Men addicted to sex, pornography, and compulsive masturbation – this study is for you
A groundbreaking clinical trial in Poland is set to examine the pharmacological treatment of compulsive sexual behaviors, particularly focusing on compulsive masturbation.
Ovarian cancer could be detected at earliest stage with 'medical tampon'
A new trial is investigating the use of a specialized tampon for the early detection of ovarian cancer by identifying biological markers in vaginal fluid.
Trial into puberty blockers for children paused over 'wellbeing concerns'
A clinical trial of puberty blockers for children has been paused due to new concerns regarding the wellbeing of participants, prompted by advocacy from JK Rowling and others.
UK clinical trial into puberty blockers paused after medicines regulator raises concerns
A UK clinical trial on puberty blockers for children has been paused following concerns from the Medicines and Healthcare products Regulatory Agency about potential long-term biological harms.
Problem with obesity drugs: patients lose too much weight, get scared, and stop taking them
A new obesity drug trial reveals significant weight loss but raises concerns as patients abandon the study due to fears of losing too much weight.
Promising drug compound attacks fat from genetic roots
A new oral drug compound, TLC-2716, shows promise in significantly reducing blood fat levels linked to fatal heart diseases.
Hope Against Triple Negative Breast Cancer: Experimental Vaccine Shows Positive Results
An experimental mRNA vaccine shows promising outcomes in a small trial for triple-negative breast cancer patients.
Initial success of a personalized vaccine against triple-negative breast cancer, the most aggressive
A clinical trial shows promising results for a personalized vaccine targeting triple-negative breast cancer, with hopes for approval within four years.
Fast method for treating depression? Scientists published promising research results
Research indicates that a single dose of dimethyltryptamine (DMT) could effectively treat severe depression that is resistant to conventional antidepressants.
Single dose of potent psychedelic drug could help treat depression, trial shows
A single dose of the psychedelic drug DMT, combined with psychotherapy, has shown promising results in treating major depressive disorder, according to a small clinical trial.
Instagram's CEO disputes "clinical addiction"
Instagram's CEO Adam Mosseri disputes the notion that individuals can be clinically addicted to social media during a trial involving Meta and Google.
'Boss' of Instagram denies 'clinical addiction' to social networks during historic trial against Meta and Google
Adam Mosseri, CEO of Instagram, refuted the idea of 'clinical addiction' to social media during a landmark trial against Meta and Google, emphasizing instead the concept of 'problematic use'.
In the trial against Google and Meta, the head of Instagram refutes the notion of 'clinical addiction'
During the trial in Los Angeles, Adam Mosseri, the CEO of Instagram, contested the idea of 'clinical addiction' to social media, opting to refer to it as 'problematic use.'
A New Way Found to Reduce 'Bad' Cholesterol Levels by up to 60%
Clinical trial results published in the New England Journal of Medicine show that new pills can reduce 'bad' LDL cholesterol levels significantly.
How researchers concluded that a more expensive dressing can make burn treatment cheaper and more efficient
A Brazilian clinical trial suggests that a more advanced and pricier dressing for deep burns can reduce patient pain, shorten hospitalization, and decrease overall treatment costs by over 30%.
Africa: Historic Africa-Led HIV Vaccine Trial Begins in Cape Town
South Africa has launched the BRILLIANT 011 clinical trial in Cape Town, marking a significant step toward developing an HIV vaccine tailored for strains prevalent in Southern Africa.
Africa: Historic Africa-Led HIV Vaccine Trial Begins in Cape Town
South Africa has launched the BRILLIANT 011 clinical trial in Cape Town, signaling a significant step towards developing an HIV vaccine tailored for strains prevalent in Southern Africa.
Scientists have a new idea for fighting depression. This method is a chance for many patients
Researchers propose a new approach to combat depression, particularly focusing on a subtype linked to immune system dysregulation, supported by recent clinical trial findings on anti-inflammatory treatments.
OAUTH unveils Nigeria’s first immunotherapy trial for colorectal cancer
The Obafemi Awolowo University Teaching Hospital has launched Nigeria's first clinical trial for colorectal cancer treatment, offering free treatments in partnership with major hospitals.
Blind Person Partially Regains Vision Through Brain Microstimulation
A patient with total blindness has regained part of their natural vision after participating in a clinical trial of electrical stimulation of the visual cortex, raising new hypotheses about the brain's ability to reactivate inactive visual circuits.
A blind person partially recovers vision with micro-stimulation of the brain
A person with total blindness caused by irreversible damage to the optic nerve has partially regained natural vision after participating in a clinical trial of electrical stimulation of the visual cortex conducted by researchers from Miguel Hernández University in Elche.
Polylaminin: a molecule discovered in Brazil 'by chance' that became hope to reverse spinal cord injuries
Polylaminin, a modified version of the naturally occurring laminin protein, is being studied as a new potential treatment for spinal cord injury victims in Brazil, although it is still in early clinical trial phases.
Children with brain cancer given hope through trial of personalised vaccines
A trial of personalized vaccines for children with brain cancer is set to begin in eight Australian hospitals, involving around 70 patients over four years.